logo
Plus   Neg
Share
Email

Array BioPharma Says BRAFTOVI + MEKTOVI + Cetuximab Meet Primary Endpoints

Array BioPharma Inc. (ARRY) reported positive results from the interim analysis of the Phase 3 BEACON CRC trial evaluating the combination of BRAFTOVI or encorafenib, a BRAF inhibitor, MEKTOVI or binimetinib, a MEK inhibitor, and ERBITUX or cetuximab, an anti-EGFR antibody or BRAFTOVI Triplet, in patients with BRAFV600E-mutant metastatic colorectal cancer or mCRC, following one or two prior lines of therapy.

The company stated that the trial met both primary endpoints of confirmed objective response rate or ORR, as assessed by Blinded Independent Central Review or BICR, and overall survival or OS.

The company plans to submit these results of the BEACON CRC trial for marketing approval in the second half of 2019.

The triplet combination of BRAFTOVI, MEKTOVI and ERBITUX for the treatment of patients with BRAFV600E-mutant mCRC is investigational and not approved by the FDA.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Retail giant Walmart announced that back-to-school essentials are available at its stores with easy, contact-free shopping options. The announcement comes as the Trump administration initiated a campaign to press state authorities to reopen schools for Fall semester, even as COVID-19 pandemic is spreading out of control in the United States. Schools across the country remain shut since March. Bed Bath & Beyond, Inc. is planning to close around 200 mostly Bed Bath & Beyond stores over the next two years amid continuing struggles with Covid-19. The home improvement retailer, which reported a wider-than-expected loss in its first quarter with sharply lower sales, said the move is part of its plans to right-size its real estate portfolio and to cut costs. United Airlines has warned that 36,000 employees or about 45% of its U.S. workforce could be furloughed in October, due to continuing losses caused by the coronavirus pandemic and collapse in air travel, according to reports citing the company's memo sent to employees.
Follow RTT